BWAY News and Press, BrainsWay Ltd. From 08/10/23

2023-08-10 16:07:33 ET Summary BrainsWay's Q2 results show continued revenue growth and improved cost control. The company is shifting its sales focus to larger institutions and enterprise customers, potentially improving sales efficiency. BrainsWay's market capitalization is ...

2023-08-09 13:29:02 ET Brainsway Ltd (BWAY) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 ET Company Participants Brian Ritchie - LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalma...

2023-08-09 07:42:03 ET Brainsway press release ( NASDAQ: BWAY ): Q2 GAAP EPS of -$0.05 beats by $0.03 . Revenue of $7.83M (-2.2% Y/Y) beats by $0.75M . Adjusted EBITDA 1 for the second quarter of 2023 was $(0.6 million), compared to $(2.9 million) for the f...

BURLINGTON, Mass. and JERUSALEM, Aug. 09, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported second quarter 2023 financial results a...

BURLINGTON, Mass. and JERUSALEM, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced three recent pub...

BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will rep...

BURLINGTON, Mass. and JERUSALEM, July 11, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the expanded mar...

2023-06-21 08:26:02 ET BrainsWay ( NASDAQ: BWAY ) has announced significant expansion of its technology platform through the recent order of 30 new Deep Transcranial Magnetic Stimulation systems for the treatment of major depressive disorder by a large TMS network of clinics b...

BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced significant expa...

2023-05-24 23:59:08 ET Summary BrainsWay has had a difficult 12 months, as a tough macro environment has overly impacted its customer base, which skews towards smaller companies. A return to growth and a renewed focus on profitability should begin moving BrainsWay towards breakeve...